Literature DB >> 28759035

SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway.

J Kim1,2, S Xu1, L Xiong2, L Yu1,3, X Fu3, Y Xu1,2.   

Abstract

SALL4 has recently been identified to promote chemo-resistance in multiple types of cancer, but the underlying mechanism remains to be fully established. Open chromatin structure is important for DNA damage response (DDR) and DNA repair. Here, we demonstrate that SALL4 promotes open chromatin by destabilizing heterochromatin protein 1α (HP1α) by recruiting ubiquitin E3 ligase CUL4B to HP1α. The silencing of SALL4 in cancer cells decreased the expression levels of Glut1 and inhibited glycolysis in cancer cells. The upregulation of HP1α in human cancer cells suppressed open chromatin, glycolysis and Glut1 expression levels. Therefore, SALL4 promotes the expression of Glut1 and open chromatin through a HP1α-dependent mechanism. Impaired DDR in SALL4-deficient human cancer cells can be rescued by the restored expression of Glut1, indicating the importance of HP1α-Glut1 axis in SALL4-mediated DDR. These findings demonstrate that SALL4 could induce drug resistance by enhancing DDR and DNA repair through promoting glycolysis and subsequent chromatin remodeling.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28759035     DOI: 10.1038/onc.2017.265

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

1.  Preparation of nuclear and cytoplasmic extracts from mammalian cells.

Authors:  Susan M Abmayr; Tingting Yao; Tari Parmely; Jerry L Workman
Journal:  Curr Protoc Mol Biol       Date:  2006-08

Review 2.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.

Authors:  Yosef Shiloh; Yael Ziv
Journal:  Nat Rev Mol Cell Biol       Date:  2013-03-13       Impact factor: 94.444

Review 3.  Function and regulation of cullin-RING ubiquitin ligases.

Authors:  Matthew D Petroski; Raymond J Deshaies
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

4.  DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Authors:  Ken A Olaussen; Ariane Dunant; Pierre Fouret; Elisabeth Brambilla; Fabrice André; Vincent Haddad; Estelle Taranchon; Martin Filipits; Robert Pirker; Helmut H Popper; Rolf Stahel; Laure Sabatier; Jean-Pierre Pignon; Thomas Tursz; Thierry Le Chevalier; Jean-Charles Soria
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

5.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

6.  Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway.

Authors:  Yael Ziv; Dana Bielopolski; Yaron Galanty; Claudia Lukas; Yoichi Taya; David C Schultz; Jiri Lukas; Simon Bekker-Jensen; Jiri Bartek; Yosef Shiloh
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

7.  Methylated H3K4, a transcription-associated histone modification, is involved in the DNA damage response pathway.

Authors:  David Faucher; Raymund J Wellinger
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

8.  Stemness factor Sall4 is required for DNA damage response in embryonic stem cells.

Authors:  Jianhua Xiong; Dilyana Todorova; Ning-Yuan Su; Jinchul Kim; Pei-Jen Lee; Zhouxin Shen; Steven P Briggs; Yang Xu
Journal:  J Cell Biol       Date:  2015-03-02       Impact factor: 10.539

9.  Heterochromatin is refractory to gamma-H2AX modification in yeast and mammals.

Authors:  Jung-Ae Kim; Michael Kruhlak; Farokh Dotiwala; André Nussenzweig; James E Haber
Journal:  J Cell Biol       Date:  2007-07-16       Impact factor: 10.539

10.  Oncogenic protein SALL4 and ZNF217 as prognostic indicators in solid cancers: a meta‑analysis of individual studies.

Authors:  Ji Cheng; Jinbo Gao; Xiaoming Shuai; Kaixiong Tao
Journal:  Oncotarget       Date:  2016-04-26
View more
  13 in total

1.  Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway.

Authors:  Jian Chen; Wenjuan Li; Ke Cui; Kaiyuan Ji; Shuxiang Xu; Yang Xu
Journal:  Oncogene       Date:  2018-05-24       Impact factor: 9.867

Review 2.  Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential.

Authors:  Yuhao Zhou; Yuan Zhan; Weiling Jiang; Huiguo Liu; Shuang Wei
Journal:  Oxid Med Cell Longev       Date:  2022-06-15       Impact factor: 7.310

3.  Zinc Finger Protein SALL4 Functions through an AT-Rich Motif to Regulate Gene Expression.

Authors:  Nikki R Kong; Mahmoud A Bassal; Hong Kee Tan; Jesse V Kurland; Kol Jia Yong; John J Young; Yang Yang; Fudong Li; Jonathan D Lee; Yue Liu; Chan-Shuo Wu; Alicia Stein; Hongbo R Luo; Leslie E Silberstein; Martha L Bulyk; Daniel G Tenen; Li Chai
Journal:  Cell Rep       Date:  2021-01-05       Impact factor: 9.423

4.  A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.

Authors:  Youqin Xu; Kaiyuan Ji; Meng Wu; Bingtao Hao; Kai-Tai Yao; Yang Xu
Journal:  Protein Cell       Date:  2019-02-01       Impact factor: 14.870

5.  Core pluripotency factors promote glycolysis of human embryonic stem cells by activating GLUT1 enhancer.

Authors:  Lili Yu; Kai-Yuan Ji; Jian Zhang; Yanxia Xu; Yue Ying; Taoyi Mai; Shuxiang Xu; Qian-Bing Zhang; Kai-Tai Yao; Yang Xu
Journal:  Protein Cell       Date:  2019-05-31       Impact factor: 14.870

6.  MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing.

Authors:  Lili Yu; Jinchul Kim; Lei Jiang; Bingbing Feng; Yue Ying; Kai-Yuan Ji; Qingshuang Tang; Wancheng Chen; Taoyi Mai; Wenlong Dou; Jianlong Zhou; Le-Yang Xiang; Yang-Fan He; Dinghua Yang; Qingjiao Li; Xuemei Fu; Yang Xu
Journal:  Nat Commun       Date:  2020-02-05       Impact factor: 14.919

Review 7.  Glycolysis-induced drug resistance in tumors-A response to danger signals?

Authors:  Fabrizio Marcucci; Cristiano Rumio
Journal:  Neoplasia       Date:  2021-01-06       Impact factor: 5.715

8.  Up-Regulation of SALL4 Is Associated With Survival and Progression via Putative WNT Pathway in Gastric Cancer.

Authors:  Yang Yang; Xiaohong Wang; Yiqiang Liu; Ying Hu; Zhongwu Li; Ziyu Li; Zhaode Bu; Xiaojiang Wu; Lianhai Zhang; Jiafu Ji
Journal:  Front Cell Dev Biol       Date:  2021-02-11

9.  SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis.

Authors:  Xu Zhang; Peng Zhang; Meng Shao; Xueyan Zang; Jiayin Zhang; Fei Mao; Hui Qian; Wenrong Xu
Journal:  Cancer Manag Res       Date:  2018-10-10       Impact factor: 3.989

10.  SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis.

Authors:  Meng Shao; Jiayin Zhang; Jiahui Zhang; Hui Shi; Yu Zhang; Runbi Ji; Fei Mao; Hui Qian; Wenrong Xu; Xu Zhang
Journal:  Cancer Cell Int       Date:  2020-05-24       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.